CTSO
CytosorbentsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CTSO Profile
Cytosorbents Corporation
A leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification
Healthcare Equipment and Supplies
04/25/2002
12/23/2014
NASDAQ Stock Exchange
149
12-31
Common stock
305 College Road East
, Princeton
, New Jersey 08540
--
Cytosorbents Corporation was incorporated in Nevada on April 25, 2002. The company is an intensive immunotherapy company in intensive care that uses blood purification to regulate inflammation, with the goal of preventing or treating life-threatening multiple organ failure. The technology is based on biocompatible, highly porous polymer adsorbent beads that can extract unwanted substances in blood and other body fluids. The technology is protected by 32 US patents.
